GRM2 and post-traumatic stress disorder: The fact that a mGluR2/3 antagonist, BCI-838, can reverse multiple PTSD-related traits in rats exposed to a blast overpressure injury while concomitantly enhancing neurogenesis in the DG indicates the involvement of glutamatergic components such as those in the hippocampus and cortex in the anxiety-related effects.